JONATHAN TORRES: Open Payments
NPI 1457890105 · GREENWICH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 20 payments from 7 companies in 2025. Trend: 2023 $202 · 2024 $281 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| PFIZER INC. | 3 | $66 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: MOUNJARO, REXULTI, AIRSUPRA, SHINGRIX, NURTEC ODT, ELIQUIS, CAPLYTA, Rybelsus.
Industry payments across NY — which companies pay providers there.
